BioPlus Acquisition Corp.
BIOSNASDAQFinancial Services
$10.80
$-0.01(-0.05%)
Market Cap$209072163
P/E Ratio—
52W High$11.68
52W Low$10.12
BioPlus Acquisition Corp. (BIOS) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BIOS · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2022-12 | 2021-12 | 2018-12 | 2017-12 | 2016-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.00B | ($0.00B) | ($0.05B) | ($0.06B) | ($0.04B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.02B | $0.03B | $0.02B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | $0.00B | ($0.07B) | ($0.02B) | $0.04B |
| Net Cash from Operations | ($0.00B) | ($0.00B) | ($0.02B) | ($0.00B) | ($0.04B) |
| Investing Activities | |||||
| Capital Expenditure | $0.00B | $0.00B | ($0.01B) | ($0.01B) | ($0.01B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | $0.00B | ($0.00B) | ($0.01B) | ($0.01B) | ($0.07B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | ($0.00B) | $0.02B | $0.08B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.00B | $0.00B | $0.01B | $0.04B | $0.11B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.00B) | ($0.00B) | ($0.03B) | ($0.01B) | ($0.05B) |
| FCF Margin %(computed) | — | — | -4.79% | -1.16% | -5.60% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more BioPlus Acquisition Corp. data
About BioPlus Acquisition Corp. (BIOS) Cash Flow Statement
BioPlus Acquisition Corp. generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2022 — a FCF margin of —. Capital expenditure was $0.00B.
Frequently asked questions
BIOS · 4 questionsBioPlus Acquisition Corp. generated free cash flow of ($0.00B) for 2022, down 81798.5% year-over-year.
BIOS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10